99 related articles for article (PubMed ID: 23650729)
1. [Comparative studies on the genotoxic activity of a new palladium (II) acidocomplex vs cisplatin in human blood lymphocytes in vitro].
Grekhova AK; Gorbacheva LB; Ivanova NA; Efimenko IA; Osipov AN
Biomed Khim; 2013; 59(1):107-14. PubMed ID: 23650729
[TBL] [Abstract][Full Text] [Related]
2. Generation of Reactive Oxygen Species in Peripheral Blood Lymphocytes of Patients with Prostate Cancer.
Grekhova AK; Gorbacheva LB
Bull Exp Biol Med; 2016 Mar; 160(5):709-11. PubMed ID: 27021086
[TBL] [Abstract][Full Text] [Related]
3. DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs.
Blasiak J; Kowalik J; Małecka-Panas E; Drzewoski J; Wojewódzka M
Teratog Carcinog Mutagen; 2000; 20(3):119-31. PubMed ID: 10820422
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571.
Wozniak K; Czechowska A; Blasiak J
Chem Biol Interact; 2004 Apr; 147(3):309-18. PubMed ID: 15135086
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the cytotoxic and genotoxic effects of cisplatin and its analogue, TNO-6, in yeast.
Hannan MA
Mutat Res; 1988 Mar; 198(1):69-72. PubMed ID: 3280985
[TBL] [Abstract][Full Text] [Related]
6. Immunospecific protein of 34.5 kDa from DNA-protein cross-links induced by cis- and trans-diamminedichloroplatinum.
Woźniak K; Walter Z
Cell Biol Int; 2002; 26(6):495-503. PubMed ID: 12119176
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cisplatin-DNA crosslinks formation with UV-C application by the alkaline Comet-assay.
Hovhannisyan GG; Haroutunyan TS; Arutyunyan RM
Exp Oncol; 2004 Sep; 26(3):240-2. PubMed ID: 15494695
[TBL] [Abstract][Full Text] [Related]
8. Fragility of telomeres after bleomycin and cisplatin combined treatment measured in human leukocytes with the Comet-FISH technique.
Arutyunyan R; Rapp A; Greulich KO; Hovhannisyan G; Haroutiunian S; Gebhart E
Exp Oncol; 2005 Mar; 27(1):38-42. PubMed ID: 15812355
[TBL] [Abstract][Full Text] [Related]
9. DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids.
Chakrabarti SK; Bai C; Subramanian KS
Toxicol Appl Pharmacol; 2001 Feb; 170(3):153-65. PubMed ID: 11162780
[TBL] [Abstract][Full Text] [Related]
10. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination.
Keller KL; Overbeck-Carrick TL; Beck DJ
Mutat Res; 2001 Jun; 486(1):21-9. PubMed ID: 11356333
[TBL] [Abstract][Full Text] [Related]
11. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate.
Błasiak J; Kowalik J
Acta Biochim Pol; 2001; 48(1):233-40. PubMed ID: 11440175
[TBL] [Abstract][Full Text] [Related]
12. Induction of DNA-protein cross-links by platinum compounds.
Woźniak K; Walter Z
Z Naturforsch C J Biosci; 2000; 55(9-10):731-6. PubMed ID: 11098823
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner.
Ferrer M; Izeboud T; Ferreira CG; Span SW; Giaccone G; Kruyt FA
Exp Cell Res; 2003 Jun; 286(2):381-95. PubMed ID: 12749865
[TBL] [Abstract][Full Text] [Related]
14. Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Kruszewski M; Bouzyk E; Oldak T; Samochocka K; Fuks L; Lewandowski W; Fokt I; Priebe W
Teratog Carcinog Mutagen; 2003; Suppl 1():1-11. PubMed ID: 12616592
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.
Johnson BW; Murray V; Temple MD
BMC Cancer; 2016 May; 16():333. PubMed ID: 27225032
[TBL] [Abstract][Full Text] [Related]
16. Study of the biological effects and DNA damage exerted by a new dipalladium-Hmtpo complex on human cancer cells.
Akdi K; Vilaplana RA; Kamah S; Navarro JA; Salas JM; González-Vílchez F
J Inorg Biochem; 2002 May; 90(1-2):51-60. PubMed ID: 12009255
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity of platinum and palladium compounds in human and bacterial cells.
Gebel T; Lantzsch H; Plessow K; Dunkelberg H
Mutat Res; 1997 Mar; 389(2-3):183-90. PubMed ID: 9093382
[TBL] [Abstract][Full Text] [Related]
19. Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA.
Yoshida Y; Izumi H; Ise T; Uramoto H; Torigoe T; Ishiguchi H; Murakami T; Tanabe M; Nakayama Y; Itoh H; Kasai H; Kohno K
Biochem Biophys Res Commun; 2002 Jul; 295(4):945-51. PubMed ID: 12127986
[TBL] [Abstract][Full Text] [Related]
20. DNA interactions of new antitumor aminophosphine platinum(II) complexes.
Neplechová K; Kaspárková J; Vrána O; Nováková O; Habtemariam A; Watchman B; Sadler PJ; Brabec V
Mol Pharmacol; 1999 Jul; 56(1):20-30. PubMed ID: 10385680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
